Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells
- PMID: 26931435
- PMCID: PMC7838699
- DOI: 10.3727/096504015X14500513118029
Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells
Abstract
In this study, the effects of hypoxia-inducible factor-1α (HIF-1α) on gastric carcinoma (GC) drug resistance through apoptosis-related genes are investigated. First, HIF-1α-specific siRNA was synthetized and transfected into drug-resistant GC cell line OCUM-2MD3/L-OHP. Then MTT assay was applied to test the inhibition rate of GC cells by 5-fluorouracil (5-FU) and oxaliplatin (L-OHP). After that, flow cytometry (FCM) was applied to measure apoptosis rate. qPCR and Western blot assay were employed to detect HIF-1α and apoptosis-related genes. Results showed that HIF-1α in OCUM-2MD3/L-OHP cells was higher than that in OCUM-2MD3 and gastric epithelial cells. After HIF-1α-siRNA transfection, inhibition rates of 5-FU and L-OHP to tumor cells increased significantly. FCM results showed that apoptosis rate of OCUM-2MD3/L-OHP cells increased significantly. After HIF-1α-siRNA transfection, survivin and Bcl-2 decreased, whereas Bax, caspase 3, and caspase 8 increased significantly. Results from this study seem to confirm that HIF-1α getting involved in GC drug resistance is possibly due to its regulation of some apoptosis-related genes. HIF-1α may be a potential target to reverse drug resistance of GC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a.PLoS One. 2015 Aug 20;10(8):e0132746. doi: 10.1371/journal.pone.0132746. eCollection 2015. PLoS One. 2015. PMID: 26292288 Free PMC article.
-
Effect of RNAi-Mediated Survivin and Hypoxia-Inducible Factor 1α Gene Silencing on Proliferation, Invasion, Migration and Apoptosis of Gastric Cancer BGC-823 Cells.Mol Biotechnol. 2024 Aug;66(8):1872-1882. doi: 10.1007/s12033-023-00786-z. Epub 2023 Jul 13. Mol Biotechnol. 2024. PMID: 37440157
-
Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.FEBS J. 2014 Jan;281(1):115-28. doi: 10.1111/febs.12577. Epub 2013 Nov 18. FEBS J. 2014. PMID: 24165223
-
Hypoxia/IL-1α axis promotes gastric cancer progression and drug resistance.J Dig Dis. 2017 Sep;18(9):511-520. doi: 10.1111/1751-2980.12496. J Dig Dis. 2017. PMID: 28608600
-
HIF in Gastric Cancer: Regulation and Therapeutic Target.Molecules. 2022 Jul 31;27(15):4893. doi: 10.3390/molecules27154893. Molecules. 2022. PMID: 35956843 Free PMC article. Review.
Cited by
-
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment.Front Cell Dev Biol. 2021 Mar 1;9:641469. doi: 10.3389/fcell.2021.641469. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33732706 Free PMC article. Review.
-
Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma.Cancers (Basel). 2020 Jul 30;12(8):2116. doi: 10.3390/cancers12082116. Cancers (Basel). 2020. PMID: 32751679 Free PMC article. Review.
-
Notch signaling molecule is involved in the invasion of MiaPaCa2 cells induced by CoCl2 via regulating epithelial‑mesenchymal transition.Mol Med Rep. 2018 Apr;17(4):4965-4972. doi: 10.3892/mmr.2018.8502. Epub 2018 Jan 26. Mol Med Rep. 2018. PMID: 29393429 Free PMC article.
-
The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance.Cancer Manag Res. 2018 Jul 4;10:1865-1874. doi: 10.2147/CMAR.S166136. eCollection 2018. Cancer Manag Res. 2018. PMID: 30013393 Free PMC article.
-
Unveiling the mechanisms and challenges of cancer drug resistance.Cell Commun Signal. 2024 Feb 12;22(1):109. doi: 10.1186/s12964-023-01302-1. Cell Commun Signal. 2024. PMID: 38347575 Free PMC article. Review.
References
-
- Zhu C. Y.; Lv Y. P.; Yan D. F.; Gao F. L. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Asian Pac. J. Cancer Prev. 14:6757–6760; 2013. - PubMed
-
- Yan L. H.; Wang X. T.; Yang J.; Kong F. B.; Lian C.; Wei W. Y.; Luo W.; Xie Y. B.; Xiao Q. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo. J. Cell Biochem. 115:34–41; 2014. - PubMed
-
- Kang J.; Zhao G.; Lin T.; Tang S.; Xu G.; Hu S.; Bi Q.; Guo C.; Sun L.; Han S.; Xu Q.; Nie Y.; Wang B.; Liang S.; Ding J.; Wu K. A peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cells. Cancer Lett. 339:247–259; 2013. - PubMed
-
- Wang Y.; Liu L.; Liu X.; Zhang H.; Liu J.; Feng B.; Shang Y.; Zhou L.; Wu K.; Nie Y.; Zhang H.; Fan D. Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes. Tumour Biol. 34:2205–2214; 2013. - PubMed
-
- Xie X.; Tang B.; Zhou J.; Gao Q.; Zhang P. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine. Oncol. Rep. 30:773–782; 2013. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous